Efficacy of Chinese medicine Yi-gan-kang granule in prophylaxis and treatment of liver fibrosis in rats

World Journal of Gastroenterology

Volumn 11, Issue 17, 2005, Pages 2583-2590

  Yao, Xi Xian ^a   Jiang, Shu Lin ^a   Tang, You Wei ^a   Yao, Dong Mei ^a   Yao, Xin ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Liver fibrosis; Prophylaxis and treatment; Rat model; Yi gan kang granule

Indexed keywords

ANGELICA SINENSIS EXTRACT; CARBON TETRACHLORIDE; CHINESE DRUG; COLLAGEN TYPE 1; MESSENGER RNA; PAEONIA RUBRA EXTRACT; PLANT EXTRACT; SALVIA MILTIORRHIZA EXTRACT; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CULTURE; CELL ISOLATION; CELL PROLIFERATION; COLORIMETRY; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EFFICACY; DRUG MECHANISM; ELECTRON MICROSCOPY; FIBRIN FORMATION; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIPID PEROXIDATION; LIVER FIBROSIS; MALE; NICK END LABELING; NONHUMAN; RANDOMIZATION; RAT; STATISTICAL SIGNIFICANCE; STELLATE CELL;

EID: 18944373129     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i17.2583     Document Type: Article

References (39)

1. Lu CB. Study of epidemic characterization and factors of hepatitis B in Chinese population. Zhonghua Ganzangbing Zazhi 1998; 6: 67-70
2. Wang BE. Severity evaluation in diagnosis of hepatic fibrosis. Zhonghua Ganzangbing Zazhi 1998; 6: 193-194
3. Friedman SL. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med 1993; 328: 1828-1835
4. Yao XX, Fu YL, Li XL. A multi-central study of Yi-Gan powder on 324 cases of chronic hepatitis. Hebei Yixueyuan Xuebao 1989; 10: 231-233
5. Yao XX, Tang YW, Yao DM, Xiu HM. Effects of Yi-gan-kang on expression of collagen I III in experimentally fibrotic rats. Shijie Huaren Xiaohua Zazhi 2001; 9: 263
6. Yao XX, Yao X, Xiu HM, Sun ZM, Song M, Feng LY. Experimental study of Yi-Gan decoction on hepatic fibrosis of rats. Weichangbing Ganbing Zazhi 2001; 10: 217
7. Shimizu I, Ma YR, Mizibuchi Y, Liu F, Miura T, Makai Y, Yasuda M, Shiba M, Horie T, Amagaya S, Kawada M, Hori H, Ito S. Effects of sho-saiko-to, a Japanese herbal medicine, on hepatic fibrosis in rats. Hepatology 1999; 29: 149-160
8. Myers DK, Slater EC. Enzymatic hydrolysis of adenosine triphosphate by liver mitochondria, activities at different pH values. Biochem J 1957; 57: 558-572
9. Zhu YH, Hu DR. Establishment and application of liver stellate cell lines. Shijie Huaren Xiaohua Zazhi 1999; 7: 348-349
10. Denizot F, Lang R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 1986; 89: 271-277
11. Iredale JP, Benyon RC, Pickering J, McCullen M, Northrop M, Pawley S, Hovell C, Arthur MJ. Mechanisms of spontaneous resolution of rat liver fibrosis. J Clin Invest 1998; 102: 538-549
12. Jia KM. Pay more attention to the study of the treatment of hepatitis B. Zhonghua Neike Zazhi 2000; 39: 797-798
13. Nie G. Studies on molecular mechanism of TCM in preventing and treating hepatopathy. Zhongguo Zhongxiyi Jiehe Zazhi 2002; 22: 318-320
14. Xu RY, Ling YB, Wang ZL, Qiu WS, Yang HZ. Gan-xian-fang treats post-hepatitis cirrhosis. Shijie Huaren Xiaohua Zazhi 1999; 7: 866-867
15. Li BS, Wang J, Zhen YJ, Wang XG, Sun YH, Wang SQ, Wu ZQ. Blocking effect of chinese herbs Yiganxian and PHGF on immuno-damaged hepatic fibrosis in rats. Shijie Huaren Xiaohua Zazhi 1998; 6: 786-787
16. Liu P, Hu YY, Xu LM. The study of anti-fibrotic effect of fuzheng-hua-yu 319 in rats. Zhongguo Shiyan Fangjixue Zazhi 1997; 3: 20-21
17. 4 -caused liver fibrosis of rats. Xin Xiaohuabing Zazhi 1997; 5: 485-487
18. Jiang SL, Li XT, Yao XX. Efficacy of prophylaxis and treatment of Yigankang on rat with hepatic fibrosis. Zhongguo Quanke Yixue Zazhi 2002; 5: 525-527
19. Jiang SL, Yao XX, Sun ZM, Song M, Yang L, Yang CJ, Yao DM, Lu T. Efficacies of prophylaxis and treatment of yigankang on fibrotic rats. Zhonghua Shiyong Yixue Zazhi 2002; 4: 10-13
20. Yao XX, Yao X, Xiu HM, Sun ZM, Song M, Feng LY. Experimental study of concentrated Yigan decoction as well as other blood-activating and stasis-eliminating drugs on hepatic fibrosis in rats. Weichangbing Ganbing Zazhi 2001; 10: 217-321
21. Yao XX, Tang YW, Yao DM, Xiu HM. Effect of Yigan decoction on the expression of type I, III collagen proteins in experimental hepatic fibrosis in rats. Shijie Huaren Xiaohua Zazhi 2001; 9: 263-267
22. Hernandez-Munoz R. Adenosine partially prevents cirrhosis induced by carbon tetrachloride in rats. Hepatology 1990; 12: 242-248
23. Wang BE. Study of animal models of experimentally immune liver fibrosis. Zhonghua Yixue Zazhi 1998; 69: 503-505
24. Shimizu I, Ma YR, Mizibuchi Y, Liu F, Miura T, Makai Y, Yasuda M. Effects of sho-saiko-to, a Japanese herbal medicine, on hepatic fibrosis in rats. Hepatology 1999; 29: 149-160
25. Wu J, Zern MA. Hepatic stellate cells: a target for the treatment of liver fibrosis. J Gastroenterol 2000; 35: 665-672
26. Pinzani M, Marra F, Carloni V. Signal transduction in hepatic stellate cells. Liver 1998; 18: 2-13
27. Pinzani M, Marra F. Cytokine receptors and signaling in hepatic stellate cells. Semin Liver Dis 2001; 21: 397-416
28. Friedman SL. Molecular regulation of hepatic fibrosis; an integrated cellular response to tissue injury. J Biol Chem 2000; 275: 2247-2250
29. Geerts A, Vrijsen R, Rauterberg J, Burt A, Schellinck P, Wisse E. In vitro differentiation of fat-storing cells parallels marked increase of collagen synthesis and secretion. J Hepatol 1989; 9: 59-68
30. Svegliati Baroni G, D'Ambrosio L, Curto P, Casini A, Mancini R, Jezequel AM, Benedetti A. Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis. Hepatology 1996; 23: 1189-1199
31. Arthur MJ, Mann DA, Iredale JP. Tissue inhibitors of metalloproteinases, hepatic stellate cells and liver fibrosis. J Gastroenterol Hepatol 1998; 13(Suppl): S33-38
32. Benyon RC, Arthur MJ. Extracellular matrix degradation and the role of hepatic stellate cells. Semin Liver Dis 2001; 21: 373-384
33. Yoshiji H, Kuriyama S, Miyamoto Y, Thorgeirsson UP, Gomez DE, Kawata M, Yoshii J, Ikenaka Y, Noguchi R, Tsujinoue H, Nakatani T, Thorgeirsson SS, Fukui H. Tissue inhibitor of metalloproteinases-1 promotes liver fibrosis development in a transgenic mouse model. Hepatology 2000; 32: 1248-1254
34. Shibata N, Watanabe T, Okitsu T, Sakaguchi M, Takesue M, Kunieda T, Omoto K, Yamamoto S, Tanaka N, Kobayashi N. Establishment of an immortalized human hepatic stellate cell line to develop antifibrotic therapies. Cell Transplant 2003; 12: 499-507
35. Ikeda H, Nagashima K, Yanase M, Tomiya T, Arai M, Inoue Y, Tejima K, Nishikawa T, Omata M, Kimura S, Fujiwara K. Involvement of Rho/Rho kinase pathway in regulation of apoptosis in rat hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol 2003; 285: G880-886
36. Kim JY, Kim KM, Nan JX, Zhao YZ, Park PH, Lee SJ, Sohn DH. Induction of apoptosis by tanshinone I via cytochrome c release in activated hepatic stellate cells. Pharmacol Toxicol 2003; 92: 195-200
37. Iredale JP, Benyon RC, Pickering J, McCullen M, Northrop M, Pawley S, Hovell C, Arthur MJ. Mechanisms of spontaneous resolution of rat liver fibrosis. J Clin Invest 1998; 102: 538-549
38. Baroni GS, D'Ambrosio L, Ferretti G, Casini A, Sario AD, Salzano R, Ridolfi F, Saccdomanno S, Jezequel AM, Benedetti A. Fibrogenic effect of oxidative stress on rat hepatic stellatecells. Hepatology 1998; 27: 720-726
39. Pietrangelo A, Gualdi R, Casalgtandi G, Geets A, De Bleser P, Montosi G, Ventura E. Enhanced hepatic collagen I mRNA expression into fat-storing cells in a rodent model of hemochromatosis. Hepatology 1994; 19: 714-721